Pictet Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$868M Buy
2025
Q4
$946M Buy
2025
Q3
$526M Sell
2025
Q2
$558M Buy
2025
Q1
$575M Buy
2024
Q4
$511M Buy
2024
Q3
$551M Buy
2024
Q2
$557M Sell
2024
Q1
$518M Buy
2023
Q4
$374M Buy
2023
Q3
$339M Buy

Other funds holding LLY

Pictet Asset Management's LLY Position: Q1 2026 in Review

Pictet Asset Management increased its Eli Lilly (LLY) stake by 7.2% in Q1 2026, buying an estimated $64.3M and bringing the position to 943,976 shares worth $868M. The position accounts for 0.92% of the portfolio, ranked #14.

Pictet Asset Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $946M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pictet Asset Management held 943,976 shares of Eli Lilly worth $868M as of Q1 2026.
  • Pictet Asset Management bought 63,470 Eli Lilly shares in Q1 2026, an estimated $64.3M.
  • Eli Lilly made up 0.92% of Pictet Asset Management's portfolio in Q1 2026, its #14 holding.
  • Pictet Asset Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Eli Lilly position peaked at $946M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.